The Journal of Antibiotics
Online ISSN : 1881-1469
Print ISSN : 0021-8820
ISSN-L : 0021-8820
Novel Squalestatins Produced by Biotransformation
ROBERT F. MIDDLETONGRAHAM FOSTERRICHARD J. P. CANNELLPHILIP J. SIDEBOTTOMNICHOLAS L. TAYLORDAVID NOBLEMARTIN TODDMICHAEL J. DAWSONGORDON C. LAWRENCE
Author information
JOURNAL FREE ACCESS

1995 Volume 48 Issue 4 Pages 311-316

Details
Abstract
Microorganisms were screened for the ability to modify the squalene synthase inhibitor squalestatin 1.
Biotransformation of 1 by two actinomycetes, SI5106 and SI5138, yielded three products hydroxylated on the 4, 6-dimethyl-oct-2-enoyl side chain either at the 6 position (5) or 7 position (4 two diastereoisomers), and lacking the acetyl ester from the C-1 side chain. Many strains were found to hydrolyse the 4, 6-dimethyl-oct-2-enoyl or acetyl esters to yield squalestatins 2 or 3.
The 3-methyl ester (6) of 1 was obtained using Fusarium sp. F13945. This fungus also produced a farnesoic acid derivative, possibly in response to inhibition of its squalene synthase by 1. The biotransformation products of 1 all retained potent squalene synthase inhibitory activity.
Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top